Broxyquinoline
![]() | |
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
5,7-Dibromoquinolin-8-ol | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Identifiers | |
| CAS Number |
521-74-4 |
| ATC code | A07AX01 (WHO) G01AC06 P01AA01 |
| PubChem | CID 2453 |
| ChemSpider |
2359 |
| UNII |
UK4C618C8T |
| ChEMBL |
CHEMBL223448 |
| Chemical data | |
| Formula | C9H5Br2NO |
| Molar mass | 302.95 g/mol |
| |
| |
| | |
Broxyquinoline is an antiprotozoal agent.
An association with exercise intolerance has been reported.[1]
References
- ↑ Swain R, Bapna JS (January 1986). "Impairment of exercise tolerance due to broxyquinoline-brobenzoxaldine combination". Hum Toxicol 5 (1): 63–4. doi:10.1177/096032718600500115. PMID 3081430.
| ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.

